NCT06122038 (TCR) is a NA clinical trial of Tart Cherry Extract Powder in Inflammation, sponsored by Lindenwood University.

Who is sponsoring NCT06122038?

NCT06122038 is sponsored by Lindenwood University.

What drugs are being tested in NCT06122038?

Interventions in NCT06122038: Tart Cherry Extract Powder, Placebo.

What condition does NCT06122038 study?

NCT06122038 studies Inflammation, Oxidative Stress, Soreness, Muscle, Muscle Damage.

Is NCT06122038 still recruiting?

NCT06122038 is currently completed. Last updated 13 January 2026.

Last reviewed 2026-01-13 · How we verify

NCT06122038: TCR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of Powdered Tart Cherries on Recovery From Repeated Sprints

Completed NA Last updated 13 January 2026

What this trial tests

NA trial testing Tart Cherry Extract Powder in Inflammation in 40 participants. Completed in 20 December 2023.

Timeline

25 April 2023

Primary endpoint
20 December 2023

20 December 2023

Quick facts

Lead sponsor	Lindenwood University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	other
Enrollment	40
Start date	25 April 2023
Primary completion	20 December 2023
Estimated completion	20 December 2023
Sites	1 location across United States

Drugs / interventions tested

Tart Cherry Extract Powder
Placebo

Conditions studied

Inflammation — all drugs for Inflammation →
Oxidative Stress — all drugs for Oxidative Stress →
Soreness, Muscle — all drugs for Soreness, Muscle →
Muscle Damage — all drugs for Muscle Damage →

Sponsor

Lindenwood University

Who can join

Adults 18 to 35, any sex, with Inflammation or Oxidative Stress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate changes in force and power production, soreness, inflammation, and oxidative stress after repeated sprinting activity and powdered tart cherry ingestion in trained males and females.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Impact of Powdered Tart Cherry Supplementation on Performance Recovery Following Repeated Sprint Exercise.
Hagele AM, Levers KS, Holley KF, Schrautemeier AC, et al · · 2026 · PMID 41683264 · DOI 10.3390/nu18030443

Verify or expand the search:

Other recruiting trials for Inflammation

Currently open trials in the same condition.

NCT07341087 — Skin Inflammation in Perimenopause: A Probiotic Intervention Proof of Concept Trial · NA · recruiting
NCT07479940 — Obesity and Aging: Impacts of Nutritional Counseling and Physical Exercise on Telomeres and Senescence Parameters · NA · active not recruiting
NCT07269847 — Comparing a Healthy Beef-Centric Diet to a Healthy U.S.-Style Diet on Metabolic Health Outcomes in Pre-Diabetic Adults · NA · recruiting
NCT07171450 — Cognitive Remediation · NA · recruiting
NCT07411612 — The Association Between Postoperative Inflammatory and Neurological Serum Biomarker Concentrations and Occurrence of Pos · recruiting

Other Lindenwood University trials

Trials by the same sponsor.

NCT07387991 — Evaluating the Ability of a Multi-Strain Postbiotic to Impact Inflammation, Immune Components, Gastrointestinal Symptoms · NA · not yet recruiting
NCT07388264 — Impact of Weizmannia (Bacillus) Coagulans JBI-YZ6.3 on Gut Health and Fecal Microbiome Changes · NA · recruiting
NCT07310108 — Evaluation of Cordyceps Militaris M2-116-04 for Its Potential Sport and Exercise Nutrition Applications in Healthy Activ · NA · completed
NCT06672952 — Dose-Response Impact of Glucosyl-Hesperidin (CitraPeak) on Exercise Performance, Blood Flow, Stress, Cognition, and Othe · NA · recruiting
NCT07502924 — Dose-Response Impact of Geranylgeraniol (GG) Supplementation on Muscle Health · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06122038 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Lindenwood University
Last refreshed: 13 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06122038.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing